DrugCite
Search

SKENAN

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Skenan Adverse Events Reported to the FDA Over Time

How are Skenan adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Skenan, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Skenan is flagged as the suspect drug causing the adverse event.

Most Common Skenan Adverse Events Reported to the FDA

What are the most common Skenan adverse events reported to the FDA?

Renal Failure Acute
39 (3.92%)
Coma
27 (2.71%)
Confusional State
25 (2.51%)
Overdose
22 (2.21%)
Miosis
18 (1.81%)
Pyrexia
17 (1.71%)
Renal Failure
15 (1.51%)
Condition Aggravated
14 (1.41%)
Somnolence
14 (1.41%)
Encephalopathy
13 (1.31%)
Fall
12 (1.21%)
Show More Show More
Hyperkalaemia
12 (1.21%)
Disturbance In Attention
11 (1.11%)
Dehydration
10 (1.01%)
Disorientation
10 (1.01%)
Hypotension
10 (1.01%)
Urinary Retention
10 (1.01%)
Pruritus
9 (.9%)
Arterial Thrombosis
8 (.8%)
Blood Alkaline Phosphatase Increase...
8 (.8%)
Blood Creatinine Increased
8 (.8%)
Cholestasis
8 (.8%)
Drug Interaction
8 (.8%)
Myoclonus
8 (.8%)
Respiratory Distress
8 (.8%)
Rhabdomyolysis
8 (.8%)
Sepsis
8 (.8%)
Tachycardia
8 (.8%)
Vomiting
8 (.8%)
Aspartate Aminotransferase Increase...
7 (.7%)
Blood Urea Increased
7 (.7%)
Bradyphrenia
7 (.7%)
Bradypnoea
7 (.7%)
C-reactive Protein Increased
7 (.7%)
Cytolytic Hepatitis
7 (.7%)
Dialysis
7 (.7%)
Gamma-glutamyltransferase Increased
7 (.7%)
General Physical Health Deteriorati...
7 (.7%)
Haemoglobin Decreased
7 (.7%)
Interstitial Lung Disease
7 (.7%)
Intestinal Ischaemia
7 (.7%)
Loss Of Consciousness
7 (.7%)
Multi-organ Failure
7 (.7%)
Respiratory Disorder
7 (.7%)
Toxic Skin Eruption
7 (.7%)
Convulsion
6 (.6%)
Epilepsy
6 (.6%)
Subileus
6 (.6%)
Altered State Of Consciousness
5 (.5%)
Blood Bilirubin Increased
5 (.5%)
Deep Vein Thrombosis
5 (.5%)
Fatigue
5 (.5%)
Lung Infection
5 (.5%)
Tremor
5 (.5%)
Acidosis
4 (.4%)
Alanine Aminotransferase Increased
4 (.4%)
Anuria
4 (.4%)
Blood Lactate Dehydrogenase Increas...
4 (.4%)
Dermatitis Exfoliative
4 (.4%)
Drug Exposure During Pregnancy
4 (.4%)
Extrapyramidal Disorder
4 (.4%)
Hallucination
4 (.4%)
Hyperhidrosis
4 (.4%)
Hypertension
4 (.4%)
Lung Disorder
4 (.4%)
Mucosal Inflammation
4 (.4%)
Pelvic Fracture
4 (.4%)
Psoriasis
4 (.4%)
Pulmonary Embolism
4 (.4%)
Respiratory Failure
4 (.4%)
Road Traffic Accident
4 (.4%)
Thrombocytopenia
4 (.4%)
Thrombosis
4 (.4%)
Transaminases Increased
4 (.4%)
Abortion Induced
3 (.3%)
Acute Respiratory Distress Syndrome
3 (.3%)
Agitation
3 (.3%)
Anaemia
3 (.3%)
Benign Prostatic Hyperplasia
3 (.3%)
Blood Creatine Phosphokinase Increa...
3 (.3%)
Bradycardia
3 (.3%)
Cholecystectomy
3 (.3%)
Cholelithiasis
3 (.3%)
Drug Abuser
3 (.3%)
Drug Dependence
3 (.3%)
Drug Intolerance
3 (.3%)
Drug Level Increased
3 (.3%)
Dysmorphism
3 (.3%)
Dyspnoea
3 (.3%)
Faecaloma
3 (.3%)
Febrile Neutropenia
3 (.3%)
Gastrointestinal Haemorrhage
3 (.3%)
Hepatitis Cholestatic
3 (.3%)
Hypercapnia
3 (.3%)
Hypertonia
3 (.3%)
Hypochloraemia
3 (.3%)
Hypokalaemia
3 (.3%)
Hyponatraemia
3 (.3%)
Hypoxia
3 (.3%)
Infantile Spasms
3 (.3%)
Jaundice Cholestatic
3 (.3%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Skenan, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Skenan is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Skenan

What are the most common Skenan adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Skenan, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Skenan is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Skenan According to Those Reporting Adverse Events

Why are people taking Skenan, according to those reporting adverse events to the FDA?

Pain
123
Drug Use For Unknown Indication
87
Product Used For Unknown Indication
18
Back Pain
18
Bone Pain
13
Sciatica
10
Show More Show More
Abdominal Pain
7
Cancer Pain
6
Chest Pain
6
Neuropathy Peripheral
4
Unevaluable Event
4
Polyarthritis
3
Arthralgia
3
Hypersensitivity
3
Analgesic Therapy
3
Neuralgia
3
Pain In Extremity
3
Pain In Jaw
3
Ankylosing Spondylitis
2
Venous Ulcer Pain
2
Osteoarthritis
2
Spinal Fracture
2
Fibromyalgia
2
Rheumatoid Arthritis
2
Joint Prosthesis User
2
Spinal Compression Fracture
2
Osteitis
2
Drug Toxicity
1
Postoperative Analgesia
1
Osteoporosis
1
Toothache
1
Muscle Spasms
1
Ankle Fracture
1
General Symptom
1
Diabetic Neuropathy
1
Analgesia
1
Breast Cancer
1
Multiple Fractures
1

Skenan Case Reports

What Skenan safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Skenan. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Skenan.